Location History:
- Newbury Park, CA (US) (2010)
- Thousand Oaks, CA (US) (2010)
- Yorba Linda, CA (US) (2013)
Company Filing History:
Years Active: 2010-2013
Title: **Innovator Spotlight: Daniel Martin Retz**
Introduction
Daniel Martin Retz is a talented inventor based in Yorba Linda, California. He has significantly contributed to the field of pharmaceutical innovations with a total of three patents registered under his name. His work mainly focuses on developing compounds that target specific kinases, with potential applications in treating various cancer-related conditions.
Latest Patents
Among his latest patents is a remarkable invention titled "Substituted Pyrimidine Compounds as RAF Inhibitors and Methods of Use." This invention presents a new class of compounds capable of modulating Raf kinase, which may be beneficial in treating Raf kinase mediated diseases such as melanomas and other cancer-related conditions. The patent elucidates a general formula for these compounds, further detailing pharmaceutical compositions and methods for treatment.
Another notable patent from Retz is that concerning "Aminopyrimidine Compounds and Methods of Use." This invention details aminopyrimidine compounds that are instrumental in treating diseases mediated by polo-like kinase 1 (Plk1). It emphasizes the therapeutic use of these compounds in combating abnormal cell growth and unwanted cell proliferation, highlighting their significance in cancer therapies.
Career Highlights
Daniel Martin Retz is currently associated with Amgen Inc., a leading biotechnology company known for its innovative approach to drug development. His expertise and research have contributed to advancing treatments that target precise biological mechanisms, showcasing his dedication to improving patient outcomes.
Collaborations
Throughout his career, Retz has collaborated with notable colleagues, including Gang Liu and Nick A Paras. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the potential impact of his inventions in the pharmaceutical landscape.
Conclusion
Daniel Martin Retz stands out as a prominent inventor, dedicated to developing innovative compounds that address critical health challenges. His work at Amgen Inc. and his recent patents reflect his commitment to advancing medical science, offering hope for more effective treatments for cancer and other diseases. As he continues to innovate, the field eagerly anticipates the positive impact his contributions will bring to patients worldwide.